A portfolio composed of Ultra SWAN stocks can deliver strong returns for investors. Read about six stock selections that can ...

Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...

The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

The most recent trading session ended with Pfizer (PFE ... alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank ...

We sifted through stock screeners, online rankings ... recently announcing a 2.4% increase in early December. Pfizer Inc. (NYSE:PFE) is focused on its oncology pipeline for future growth, with its ...